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1. Introduction 
The treatment of diabetes mellitus can be compli- 
cated by the immunogenicity of the insulin prepara- 
tions used. Local reactions occur in a significant 
proportion of patients and it has been reported that 
every subject receiving porcine or bovine insulins 
shows insulin binding antibodies shortly after the 
beginning of treatment [ 11. These circulating antibodies 
cause an increase in the insulin requirement over a 
period of time. Opinions vary as to whether the 
immunogenicity is due to the actual insulin molecules 
or because of other components present in the 
preparations but it is possible that antibody production 
is an inevitable consequence of repeated injections of 
a molecular species different from human insulin. 
Antibodies are presumably directed towards the 
determinants to which the species is capable of 
responding. Porcine and human insulins differ by only 
one amino-acid residue but bovine and human insulins 
have three residues changed and it is interesting that 
there is evidence that bovine insulin produces 
significantly more antibodies than porcine in the 
diabetic patient [2]. 
Because of indications that high molecular weight 
components of insulin preparations were particularly 
immunogenic, Schlichtkrull et al. [3] and Root et al. 
[4] sought to remove impurities by ion-exchange 
chromatography and have shown that the purified 
insulins were of reduced immunogenicity. The major 
identified impurities in the insulin preparations 
appeared to be arginine3 1 insulin, desamido insulin 
and ethyl ester together with proinsulin and intermed- 
iates. 
The difference between porcine and human insulins 
is that the C-terminal residue of the B chain is alanine 
in the porcine and threonine in the human peptide. 
Carboxypeptidase A will remove the B chain C-terminal 
amino-acid faster than the A-chain asparagine and it is 
possible to obtain a des-alanyl peptide with the same 
sequence as the corresponding human peptide [S] . 
The use of this insulin in patients resistant to other 
insulins has been described and significant improve- 
ment in the control of the diabetes has been reported 
in some cases [6]. This supports the view that a 
readily modified insulin could have a place in diabetic 
therapy and one such method is described in this letter. 
It has been shown that the fruiting body of the 
fungus Armillaria Mellea produces a proteolytic enzyme 
[7] and that this protease has pronounced specificity 
towards amide bonds formed on the amino side of a 
lysine residue (P. L. Walton, personal communication). 
The specificity has been confirmed and utilised in 
structural studies on aspartate amino-transferase [8 ] . 
Porcine, bovine and indeed most other insulins have 
a single lysine residue at the penultimate position of 
the B chain and cleavage at this point would remove a 
dipeptide containing the C-terminal residue foreign to 
the human molecule. Additionally the proinsulins have 
a second lysine residue giving the sequence -lysine- 
arginine-A-chain [9,10] . An examination of the effect 
of the Armillaria Mellea protease upon insulin 
preparations was therefore undertaken to investigate 
whether modified insulins could be obtained which 
would retain the essential biological activity of insulin 
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2. Materials 
Porcine insulin (NT.51) was obtained from The 
Boots Company, Nottingham, and bovine insulin 
(Lot 4189.5) from Burroughs Wellcome & Co, London. 
The purified A. Mellea protease was kindly provided 
by Dr P. L. Walton, ICI Pharmaceuticals Division. 
3. Results and discussion 
The first experiments were carried out on ten times 
recrystallised porcine insulin with an enzyme substrate 
ratio of I:200 in 0.1 M ammonium bicarbonate at 
37°C. Progress of the reaction was followed by 
dansylation [ 121, whereby N-terminal ammo-acids 
were identified as their dansyl derivatives, and this 
showed that the only new N-terminal acid was in fact 
lysine. A portion of the digest was resolved into two 
components by paper electrophoresis. The spot 
showing greatest movement to the cathode at pH 2.1 
was found to be the dipeptide lysyl alanine and the 
second component with only N-terminal glycine and 
phenylalanine had the amino-acid ratios of the l-49 
unit. #en insulin alone was subjected to a standard 
single column amino-acid analysis programme 
(Locarte Company, London) it appeared as a single 
peak about 50 min before the ammonia peak. The two 
cleavage products appeared as separate peaks in the 
same region and subsequently an abbreviated 
programme was used to separate the three components 
(fig.1). This allowed for rapid estimation of the three 
components and it was found that even with heavy 
loading only these three could be seen. Several aspects 
of this enzymic modification of insulin were followed 
using the automated analysis programme. 
i) Experiments at different enzyme substrate ratios 
were carried out at 37°C in 0.1 M ammonium 
bicarbonate with the insulin concentration at 2 mg/ml. 
The stock enzyme solution was approximately 0.5 mg/ml 
but the ratio of enzyme to insulin was established by 
amino acid analyses of acid hydrolysates from aliquots 
of the starting solutions. The results showed that 
cleavage of insulin could be achieved in a few hours 
with enzyme substrate ratios of less than 1: 1000. 
This ratio was used thereafter. 
ii) The influence of pH upon reaction rate was 
followed using ammonia and acetic acid to give 
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Fig.1. Reproduction of the 570 nm trace showing the 
separation of insulin (2) from deslysylalanyl insulin (1) and 
lysyl alanine (3) at 58°C on the 23 cm column of a Locarte 
amino acid analyser equilibrated with pH 3.25 buffer and 
then eluted with pH 6.65 buffer. 
solutions of the desired pH values and, to ensure 
solubility, the insulin concentration was 400 pg/ml. 
Aliquots were taken for each pH value from a stock 
enzyme-insulin solution prepared at 0”. Samples were 
analysed at 1 and 4 hr and this showed that digestion 
took place quite satisfactorily from pH 4-9 at 
37°C (fig.2). 
iii) The reaction was followed at different tempera- 
tures, at pH 8.2 and with an insulin concentration of 
400 /Is/ml. Below ambient temperature digestion was 
very slow but the rate increased up to 50°C. Above 
this temperature it was more erratic but with a tenden- 
cy towards a slower reaction in some experiments. 
iv) The effects of different metal salts on the rate 
of digestion were followed at pH 8.2, 37°C insulin at 
1 mg/ml and with the enzyme substrate ratio held at 
1: 1000. Profound effects were observed at very high 
metal concentrations - one series is shown in table 1. 
Clearly calcium and magnesium ions enhance the rate 
of cleavage of the insulin molecule whereas cobalt, 
manganese and zinc are inhibitory. It has not been 
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Fig.2. Influence of pH upon the cleavage of insulin by the 
protease from A. Mellea; lower line after 1 hr, upper line 
after 4 hr. 
established whether these effects are due to interaction 
with the enzyme, with the insulin or with both. 
Both porcine and bovine insulins have been treated 
with enzyme on several occasions on the several 
hundred milligram scale. Concentrations up to 
100 mg/ml were used with either buffered solutions or 
Table 1 
Effect of metal chlorides upon the AM protease-insulin 
reaction 
Molarity 
lo- ’ lo-2 lo-3 1o-4 
Ca++ a2 78 79 64 
Mg++ 88 76 77 59 
co++ 13 14 42 69 
Mn” 10 12 47 45 
Zn++ 0 0 36 34 
Percentage reaction after 4 hr; control value 61%. 
with the pH held at the chosen value by the automatic 
addition of sodium hydroxide. The enzyme substrate 
ratio of 1: 1000 was usually adhered to, sometimes 
calcium or magnesium ions were used, and tempera- 
tures were maintained between 35-40°C. The 
progression of the reaction was followed by automatic 
analysis of aliquots to determine both the amount of 
insulin and of the two products. Analysis took approx. 
90 min and the reactions were terminated when all the 
insulin had been digested. The digests were purified by 
gel chromatography and, as with insulin [3], it was 
found that the 49 residue molecule behaved as the 
monomer in aqueous acetic acid. At the conclusion of 
the reaction the digest was immediately adjusted to a 
20% solution in acetic acid and purified using Sephadex 
G-50 in 20% acetic acid solution. Comparable recoveries 
Fig.3. Acrylamide gel electrophoresis in Tris-HCl buffer 
pH 8.9 with staining by amido black of (1) bovine insulin (2) 
deslysylalanyl bovine insulin (3) porcine insulin (4) 
deslysylalanyl porcine insulin each previously purified by gel 
chromatography. 
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of over 90% were obtained using insulin and deslysyl- 
alanyl insulin after gel chromatography. Amino acid 
analyses of acid hydrolysates showed the complete 
absence of lysine in the products from both bovine 
and porcine insulins. Dansylation showed only 
N-terminal phenylalanine and glycine together with 
the 0tyrosine derivative. Thin-layer acrylamide gel 
electrophoresis at pH 8.9 showed that the modified 
peptides moved faster to the anode than the insulins 
themselves (fig.3). Trace spots which moved marginally 
faster than the main ones probably represented the 
desamido insulin in which aspargine 21 was replaced 
by aspartic acid; this feature would be retained after 
enzymic modification. 
Impurities present in insulin preparations may well 
be involved in the production of antibodies to the 
insulins. All the lysine containing peptides examined 
so far are broken by the enzyme; glucagon, for example 
is rapidly degraded to give two smaller fragments. 
There is every reason to expect, therefore, that the 
lysine containing contaminants of the insulin prepara- 
tions would also be degraded thereby allowing cleaner 
preparations to be obtained. 
The two insulin derivatives showed similar effects 
upon blood sugar levels as the parent molecules using 
a rabbit hypoglycaemic assay (US Pharmacopeia 
Vol. 18, D. C. Earl, personal communication) and 
would therefore be acceptable alternatives on the 
grounds of potency. 
Attempts have been made to show that the enzyme 
was completely separated from the products by gel 
chromatography and to see if the enzyme could be 
re-used. These are important points for any practical 
application of the process. Using a mild method of 
iodination [ 131, about 2 pg of enzyme was labelled 
with 12’ I and purified using Sephadex G-25. 
Additional enzyme was added to the radioactive 
material and then this was subjected to the acetic acid 
Sephadex G-50 gel chromatography process. The 
recovered radioactive enzyme was used to digest 
porcine insulin under the usual conditions apart from 
a higher enzyme substrate ratio 200 pg to 50 mg insulin. 
The digest was resolved by gel chromatography (tig.4) 
and the enzyme fractions were combined and 
lyophilysed. The recovered enzyme was used to digest 
a second batch of insulin (20 mg), recovered as before 
and again used with porcine insulin (20 mg). In the 
latter case less than 10% of the insulin remained after 
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Fig.4. Separation of deslysylalanyl insulin (2) and “‘1 
labelled enzyme (1) using a column (160 X 2 cm) of Sephadex 
G50 in 20% aqueous acetic acid at 4°C. 
12 hr incubation. This does not of course provide an 
accurate measurement of the potency retained by the 
enzyme but does indicate that it is sufficiently robust 
to remain at least partially functional through several 
cycles of 20% acetic acid at 4°C lyophilysations and 
incubations at pH 8 at 37°C. Gel chromatography 
separated enzyme and insulin efficiently but a small 
amount of radioactivity (s 5%) remained in the 
insulin area after the first cycle but was not apparent 
in subsequent cycles. This could be reduced 
considerably by simple reprecipitation of the 
deslysylalanyl insulin. Attempts to obtain crystals 
from the 1-49 residue peptide have failed so far using 
conditions under which insulin itself crystallised 
readily [ 141. 
These experiments show that a complete and 
specific cleavage of the C-terminal dipeptide of the 
B chain of insulins can be achieved using the protease 
from Armillaria Mellea. Gel chromatography provides 
a simple method of isolating the 49 residue products, 
and studies are proceeding on their capacity to cause 
a lower production of insulin binding antibodies. 
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